The widow of a 48-year-old man was awarded $6.3 million this week after her husband, who’d been cleared of CVD by his cardiologist six weeks before his death, suffered a fatal heart attack while jogging.

The odds of a successful and effective TMVR for the treatment of mitral regurgitation increase alongside an operator’s level of experience, a study published in the Journal of the American College of Cardiology has found.

Frailty and cognitive decline may cause geriatric patients to fare worse in a traditional cardiac ICU than expected, according to a Dec. 9 scientific statement from the American Heart Association.

Atrial fibrillation patients who are obese are less likely to respond to sodium channel blockers than their normal-weight peers, according to a new study.

Natural compounds mixed into THC vaping liquids could generate toxic chemicals when heated and inhaled, according to research out of Portland State University in Oregon.

A report published in the European Heart Journal Dec. 10 suggests middle-income countries in Europe suffer most heavily from CVD morbidity and mortality.

Diagnosed cases of chronic heart failure are expected to number 32 million by 2028, according to a report from analytics company GlobalData.

Updated screening technologies and more widespread use of statins have rendered aspirin ineffective for the primary prevention of CVD, according to a study published in Family Practice.

Results from the National Youth Tobacco Survey, released Dec. 5 by the CDC, reveal that 6.2 million middle- and high-school students have used a tobacco product in the past month.

Patients with atrial fibrillation may be more likely to stick to a regimen of oral anticoagulation if they’re first prescribed OACs in the emergency department, according to a study published Dec. 9 in the Canadian Medical Association Journal.